Author Information
Paul Gerard Richardson is a renowned researcher affiliated with the Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. He has made significant contributions to the field of cancer research, particularly in multiple myeloma.Research Contributions
Paul Gerard Richardson has authored numerous impactful papers, with a specific focus on multiple myeloma. His research spans various aspects of the disease, including treatment options for relapsed/refractory multiple myeloma, the use of antibody-drug conjugate therapies, and the emerging importance of clonal hematopoiesis. In 2022 alone, he published several papers addressing pivotal topics such as defibrotide therapy for SARS-CoV-2 ARDS, the effectiveness of daratumumab in Black patients with newly diagnosed multiple myeloma, and the detection of treatment failure using cell-free DNA.Aliases
Paul Gerard Richardson has published under several aliases, including Paul G. Richardson, Paula Richardson, P Richardson, P G Richardson, P. Richardson, P G G Richardson, and P. G. Richardson.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
110,486 |
| h-index |
165 |
| Paper Count |
1,699 |
